Instruction for use: Dithranol (Dithranolum)

Pharmacological group

dermotropic means

Nosological classification (ICD-10)

L40 Psoriasis

Chronic psoriasis with diffuse plaques, Generalized psoriasis, Psoriasis of the scalp, Psoriasis of the scalp, Generalized form of psoriasis, Psoriasis dermatitis, Psoriasis complicated by erythroderma, Invalidative psoriasis, Isolated psoriatic plaque, Exfoliative psoriasis, Psoriatic Erythroderma, Psoriasis with eczematosis, Hyperkeratosis in psoriasis,Inverse psoriasis,Psoriasis eczematous, Dermatosis of psoriasis, Psoriasis of the genitals, Psoriasis with lesions of hairy areas of skin, Erythrodermal psoriasis, Chronic psoriasis of the scalp, Chronic psoriasis, Ordinary psoriasis, Refractory psoriasis, Kebner phenomenon, Scaly lichen

Code CAS 480-22-8

Pharmacology

Pharmacological action - keratolytic, antipsoriatic.

Slows down the process of mitosis and proliferation of epidermal cells, reduces the rate of protein synthesis.

Application of Dithranol

Psoriasis (common forms).

Contraindications

Hypersensitivity, psoriatic erythroderma and pustular psoriasis, kidney stone disease, childhood.

Side effects

Inflammatory reactions and pigmentation of the surrounding healthy skin.

Routes of administration

Outwardly.

Precautions for the Dithranol

When applying the ointment, it is advisable to use disposable gloves. It is necessary to protect the face and mucous membranes of the eyes. You can not rub the ointment into wrinkles and depressions of the skin. The expressed reddening of the skin along the contour of the psoriatic areas is the reason for the withdrawal of the drug. It is not recommended long-term use or application to large areas during pregnancy.